Pharmaceuticals

LUDIPRESS

Ludipress® is a co-processed excipient with a composition of 91.1 – 94.9% Lactose monohydrate, 3.0 – 4.0% Povidone (Kollidon® 30) and 3.0 – 4.0% Crospovidone (Kollidon® CL). The product is obtained by wet granulation. It is supplied as white to light yellow granules. It is supplied as white, free-flowing and tasteless granules. Benefits • A three-in-one system comprising filler, binder and disintegrant with very low hygroscopicity and excellent flowability US FDA approved and IID-listed (inactive ingredient database) • Accelerated product development and process validation • With Ludipress®, you save precious time on developing, analysing and blending. You simply add your active ingredient, a lubricant, and compress your tablets - it is that easy • Reduced costs – for storage, production and analysis • Quick and easy tablet compression resulting in outstanding tablets with rapid disintegration in spite of ideal hardness, low friability and fast active ingredient release
LUDIPRESS
By: BASF


Technical Description of LUDIPRESS

Product:
LUDIPRESS
Principal:
BASF
CAS Number:
-
Chemical/Common Name:
-
Product Number:
290058

Do you want to read more about LUDIPRESS?

Full access also means:

Your personal sales representative

Product documentation

Product support

Overview of products relationships

Meaningful insights from our experts

Order placing & order tracking

Hi there, how can we help you?

LUDIPRESS - BASF | IMCD Kenya